Nagata Y, Jojima K, Matsukawa T, Tomisaki I, et al. Initial-to-nadir Prostate-specific Antigen Ratio Predicts Response to First-line Enzalutamide in Metastatic Castration-resistant Prostate Cancer. Anticancer Res 2023;43:4573-4581.
PMID: 37772559